Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5M 394M |
---|---|---|---|---|---|
Net income 2024 * | -11M -867M | Net income 2025 * | -13M -1.03B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.45
x | P/E ratio 2025 * |
-0.43
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.74% |
Latest transcript on Processa Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 28/03/11 |
Sian Bigora
FOU | Founder | 63 | 28/03/11 |
David Young
FOU | Founder | 71 | 28/03/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 07/08/23 |
James Neal
BRD | Director/Board Member | 68 | 15/07/22 |
Justin Yorke
CHM | Chairman | 58 | 01/10/17 |
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |